This document discusses the expanding role of statisticians in the biopharmaceutical industry. It notes that statisticians can provide value in all phases of clinical drug development, from pre-clinical research to data analysis and reporting results. The document advocates for statisticians to have a more prominent role earlier in the drug development process when knowledge creation is most impactful. It also highlights how statisticians are needed to properly analyze complex new data types and collaborate cross-functionally with other experts.